42
PATHOLOGY OF BRAIN TUMOURS - THE SUBREGIONAL EXPERIENCE E.E.U. AKANG, MBBS Professor of Pathology, University of Ibadan, Nigeria Consultant Pathologist, Department of Pathology, University College Hospital, Ibadan, Nigeria CLINICAL NEUROSCIENCE REVIEW CONFERENCE AUGUST 8 - 10, 2011 IBADAN, NIGERIA

Pathology of brain tumors the subregional experience

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Pathology of brain tumors   the subregional experience

PATHOLOGY OF BRAIN TUMOURS - THE SUBREGIONAL

EXPERIENCEE.E.U. AKANG, MBBS

Professor of Pathology, University of Ibadan, NigeriaConsultant Pathologist, Department of Pathology, University

College Hospital, Ibadan, Nigeria

CLINICAL NEUROSCIENCE REVIEW CONFERENCEAUGUST 8 - 10, 2011

IBADAN, NIGERIA

Page 2: Pathology of brain tumors   the subregional experience

E k’abo! Welcome to Ibadan!

Page 3: Pathology of brain tumors   the subregional experience

Introduction 1• Central nervous system (CNS) tumours

are a diverse group of neoplasms• Each neoplasm has distinctive biology,

treatment and prognosis• High-grade CNS neoplasms are among

the most aggressive and intractable types of cancer

Page 4: Pathology of brain tumors   the subregional experience

Introduction 2•Cancer is the leading cause of death in developed and the 2nd most common cause in developing nations•Age-standardised mortality rates for CNS tumours is 3.6 in developed and 2.9 per 100,000 in developing nations

Page 5: Pathology of brain tumors   the subregional experience

Historical background•CNS tumours were believed to be rare in native Africans up until half a century ago•Expanding general/specialist medical services have led to increasing recognition of CNS tumours•Most of the early reports from the sub region have been clinical neurosurgery series

Page 6: Pathology of brain tumors   the subregional experience

144 million population35,000 medical doctors<500 pathologistsPer capita (p.c.) income $300Health budget $50 p.c.

6

307 million population814,000 medical doctors* *How many of these are Nigerians?20,000 pathologists*Per capita (p.c.) income $39,000Health budget $2,250 p.c. 6

Page 7: Pathology of brain tumors   the subregional experience

Early studies in Africa•Necropsy-based studies were the 1st reports of CNS tumours in tropical Africa•Strachan, 1934- South Africa- less common in Bantus than other races•Davies, 1957- 6 gliomas among 2162 PMs- not uncommon•Jackson & Okubadejo, 1963- well-illustrated report of 13 CNS tumours among 3489 PMs- uncommon

Page 8: Pathology of brain tumors   the subregional experience

MeningiomaWAMJ 1963; 12:251-263

3 meningiomas

2 astrocytomas

2 pituitary adenomas

1 pinealoma

Page 9: Pathology of brain tumors   the subregional experience

WAMJ 1963; 12:251-263Case reported as medulloblastoma

14 yr F- left frontal lobe mass

Could this be a PNET or an anaplastic astrocytoma?

3 cases of medulloblastoma- 14 yr F- frontal lobe; 30 yr M- Lt thalamus, cerebellum and midbrain; 4 yr F- basal ganglia and optic n.

Page 10: Pathology of brain tumors   the subregional experience

WAMJ 1963; 12:251-263Case reported as ependymoma

15 year old male with fibrosarcoma of thigh with lung metastases and dura based intracranial tumour

Page 11: Pathology of brain tumors   the subregional experience

Later studiesOdeku & Janota 1967- 3 yrs after establishment of Neurosurgery at UCH, Ibadan- “not so rare”48 intracranial masses 44 neoplasms; neurogenous neoplasms (47.7%), meningiomas (22.9%), sellar region (15.9%)

Ohaegbulam et al 1980- 43 intracranial neoplasms from EnuguGliomas (23.2%), sellar region (20.9%), meningioma (18.6%)

Page 12: Pathology of brain tumors   the subregional experience

Other early African studies• Kasili et al 1971- Kenya 97 intracranial tumours; gliomas 45%, meningiomas

28%• Collomb et al 1973- Senegal187 intracranial neoplasms and 33 inflammatory

masses Gliomas, meningiomas, sellar region tumours• Sorour et al 1973- EgyptTwo series 291 clinical and 377 autopsyGliomas, meningiomas- high incidence

Page 13: Pathology of brain tumors   the subregional experience

Ibadan- 1980-1997East Afr Med J 2000; 77:1-5

Olasode et al 2000- 2nd and 3rd generations of Ibadan neurosurgeons210 histologically confirmed CNS neoplasms- 135 (64.3%) adults & 75 (35.7%) childrenGliomas most common, followed by metastases (choriocarcinoma and Burkitt’s lymphoma)Sellar region tumours predominate in children

Page 14: Pathology of brain tumors   the subregional experience

Ibadan- 1991-2007Sahabi 2008- 3rd generation of Ibadan neurosurgeonsProgressive increase in CNS tumour rates356 histologically confirmed CNS neoplasms- 264 (74.2%) adults & 92 (25.8%) childrenGliomas most common, followed by meningiomas. Female predominance in meningiomas; Reduced metastases, with decline in choriocarcinoma

Page 15: Pathology of brain tumors   the subregional experience

Sahabi, 2008

Page 16: Pathology of brain tumors   the subregional experience

Gender distribution among tumour groups

Page 17: Pathology of brain tumors   the subregional experience
Page 18: Pathology of brain tumors   the subregional experience

Pilocytic astrocytomaSahabi, 2008

Page 19: Pathology of brain tumors   the subregional experience

Gemistocytic astrocytomaSahabi, 2008

Page 20: Pathology of brain tumors   the subregional experience

Anaplastic astrocytomaSahabi, 2008

Page 21: Pathology of brain tumors   the subregional experience

OligodendrogliomaSahabi, 2008

Page 22: Pathology of brain tumors   the subregional experience

Meningiomas-Sahabi, 2008

HISTOLOGICAL TYPES

HISTOLOGICAL SUBTYPES

WHO GRADETOTAL

I II III

Meningioma

Secretory 3 0 0 3Anaplastic 0 0 7 7Atypical 0 3 0 3Angiomatous 2 0 0 2Psammomatous 5 0 0 5Meningothelial 21 0 0 21Fibroblastic 8 0 0 8Transitional 45 0 0 45

Mesenchymal tumours Haemangiopericytoma 0 3 1 4

Other Haemangioblastoma 3 0 0 3TOTAL 87 6 8 101

Page 23: Pathology of brain tumors   the subregional experience

Odebode et al, 2002Unpublished observations

Morphological variants

Nigeria(1972)N=38

Nigeria (2002)N=60

Turkey (1997)N=203

S’Arabia (1996)N=131

Canada (1983)N=114

USA (1982)N=51

Norway (1974)N=256

Transitional - 55 19 23 42.1 37.3 6Meningothelial 44.7 26.6 30.5 34 34.2 35.3 52

Psammomatous 23.7 1.7 7 3 - 9.8 -Fibrous 7.9 1.7 26 23 20.2 7.8 14Angiomatous 5.3 1.7 3.5 5 0.9 - 5

Mixed patterns 18.4 - - - - - 23

Sclerosing - - - 10.7 - - -

Chordoid - - - 0.8 - - -

Hemangiopericytoma - 8.3 - - - - -

Papillary - - - - - 9.8 -

Anaplastic - 5.0 13 - 2.6 - -

Atypical - - 1 - - - -

Page 24: Pathology of brain tumors   the subregional experience

Meningioma- secretorySahabi, 2008

Page 25: Pathology of brain tumors   the subregional experience

Meningioma- transitionalSahabi, 2008

Page 26: Pathology of brain tumors   the subregional experience

CraniopharyngiomaSahabi, 2008

Page 27: Pathology of brain tumors   the subregional experience

Metastatic CNS neoplasmsSahabi, 2008

Page 28: Pathology of brain tumors   the subregional experience

Metastatic choriocarcinomaSahabi, 2008

Page 29: Pathology of brain tumors   the subregional experience

Lagos University Teaching Hospital

Page 30: Pathology of brain tumors   the subregional experience

LAGOS- 2001-2011Awelimobor 2011- 1st and 2nd generation of Lagos neurosurgeonsProgressive increase in CNS tumour rates110 CNS neoplasms- 76.4% adults & 23.6% childrenMeningioma (30.9%), pituitary adenoma (20%) and astrocytic tumours (19%). Metastases in 3.5%.

Page 31: Pathology of brain tumors   the subregional experience

CraniopharyngiomaAwelimobor, 2011

Page 32: Pathology of brain tumors   the subregional experience

PAEDIATRIC CNS NEOPLASMS 1

• Age standardised incidence rates for childhood CNS neoplasms is 25-40 per 106 in developed countries and <15 per 106 in developing nations• Due partly to under ascertainment

and partly to racial factors

Page 33: Pathology of brain tumors   the subregional experience

PAEDIATRIC CNS NEOPLASMS 2IBADAN•Aghadiuno et al- 89 CNS neoplasms (1960-1982)- Astrocytoma, medulloblastoma, ependymoma and oligodendroglioma•Olasode- astrocytoma, craniopharyngioma and medulloblastoma•Overall increase with fewer Burkitt’s casesENUGU- Izuora et alCraniopharyngioma (38%), astrocytoma and medulloblastoma (14% each)

Page 34: Pathology of brain tumors   the subregional experience

PAEDIATRIC CNS NEOPLASMS 3

• Karkouri et al reviewed 542 CNS neoplasms in Morrocco

• Astrocytoma and medulloblastoma were most common

• Emphasised the need for population based registry to assess true burden of these neoplasms

Page 35: Pathology of brain tumors   the subregional experience

INTRAOPERATIVE CONSULTATIONA primary role of pathologist in patient management-Gross examination-Frozen section-CytologyAwelimobor 2011- 100% concordance rate between cytological and frozen section diagnosis, as well as between frozen section and routine paraffin embedded tissue diagnosis

Page 36: Pathology of brain tumors   the subregional experience

Glioblastoma- cytology, Frozen section and permanent section

Awelimobor, 2011

Page 37: Pathology of brain tumors   the subregional experience

Pituitary adenoma- cytology and frozen sectionAwelimobor, 2011

Page 38: Pathology of brain tumors   the subregional experience

Meningioma- cytology, Frozen section and permanent section

Awelimobor, 2011

Page 39: Pathology of brain tumors   the subregional experience

COMPARISON OF SELECTED AFRICAN SERIESTUMOUR TYPES

Ibadan 1957-1969N = 116*

Ibadan 1980-1990

N = 210

Ibadan 1991-2007

N = 356

Lagos 2001-2010

N = 110

Senegal 1960-1971

N = 187

Kenya 1968-1971

N = 97

Egypt 1956-1962N = 315*

Astro 15 (12.9) 53 (25.3%) 88 (24.7%) 21 (19.1%) 64 (34.2%) 33 (34%) 99 (31.4%)

Oligo 1 (0.9) 8 (3.8) 8 (2.2) 1 (0.9) 0 (0) 0 (0) 5 (1.6)

Ependymal 6 (5.2) 1 (0.5) 11 (3.1) 3 (2.7) 6 (3.2) 5 (5.2) 28 (8.9)

Choroid 0 (0) 0 (0) 1 (0.3) 2 (1.8) 3 (1.6) 1 (1) 3 (9.5)

Neuronal/Glial

0 (0) 0 (0) 8 (2.2) 0 (0) 0 (0) 0 (0) 0 (0)

Pineal 5 (4.3) 0 (0) 2 (0.6) 1 (0.9) 0 (0) 1 (1) 13 (4.1)

Embryonal 6 (5.2) 8 (3.8) 25 (7) 5 (4.5) 5 (2.7) 4 (4.1) 15 (4.8)

Cranial nerve

1 (0.9) 0 (0) 1 (0.3) 1 (0.9) 4 (2.1) 3 (3.1) 27 (8.6)

Meningeal 19 (16.4) 24 (11.4) 104 (29.2) 37 (33.6) 35 (15.9) 24 (24.7) 75 (23.8)

Lymphoma

0 (0) 0 (0) 1 (0.3) 0 (0) 0 (0) 0 (0) 0 (0)

Germ cell 2 (1.7) 3 (1.4) 1 (0.3) 0 (0) 0 (0) 0 (0) 0 (0)

Sellar region

24 (20.7) 55 (26.1) 78 (21.9) 31 (28.2) 14 (7.5) 13 (13.4) 28 (8.9)

Metastatic 21 (18.1) 48 (23) 31 (8.7) 5 (4.5) 26 (13.9) 10 (10.3) 14 (4.4)

Page 40: Pathology of brain tumors   the subregional experience

CONCLUDING REMARKS•Pathologists in the sub region faces enormous challenges in terms of diagnostic facilities•Biologic characteristics of CNS neoplasms in developing countries have been discussed •Expansion of adult/pediatric neurologic/neurosurgical facilities requires increased sophistication of routine laboratory diagnostic methods•This can be facilitated by training and research linkages between centers in developing and developed countries.

Page 41: Pathology of brain tumors   the subregional experience

LIST OF REFERENCES

Page 42: Pathology of brain tumors   the subregional experience

Thanks for listening!Have a safe trip home!O d’abo!